VB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression

colimiR-3D, a novel microRNA-based blood test, is designed to enable earlier intervention and personalized management of adolescent idiopathic scoliosis based on progression risk